PMVP - PMV Pharmaceuticals Inc Stock Price & Dividend Safety Sector: Healthcare | Exchange: NASDAQ Global Select Current Price & Safety Score Price: 1.25 USD StockBonds Safety Grade: F Altman Z-Score (Bankruptcy Risk): -6.48 StockBond Score: -0.73 Company Description PMV Pharmaceuticals Inc operates as a precision oncology company focused on discovering and developing both small molecule and tumoragnostic therapies to address p53 mutations in cancer patients Their leading experimental drug PC14586 is a small molecule designed to correct the p53 protein specifically when it contains the Y220C mutation thereby restoring its natural functional state The company is also progressing a pipeline of other programs targeting various mutant p53 forms including Wildtype p53 InducedPhosphatase R282W R273H and other prevalent p53 hotspot mutations Originally known as PJ Pharmaceuticals Inc the firm rebranded to PMV Pharmaceuticals Inc in July 2013 The company was founded in 2013 and has its main operational base in Cranbury New Jersey